scanX
Home
Alembic Pharmaceuticals

Alembic Pharmaceuticals

1,191.95
-13.55
(-1.12%)
Market Cap (₹ Cr.)
₹23,693
52 Week High
1,284.95
Book Value
₹245
52 Week Low
707.15
PE Ratio
37.61
PB Ratio
4.92
PE for Sector
38.75
PB for Sector
4.65
ROE
12.78 %
ROCE
13.79 %
Dividend Yield
0.91 %
EPS
₹32.05
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
10.64 %
Net Income Growth
80.07 %
Cash Flow Change
10.95 %
ROE
63.34 %
ROCE
65.23 %
EBITDA Margin (Avg.)
22.23 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
494
574
918
895
591
698
837
805
648
590
770
755
839
812
1,097
908
850
900
1,135
1,053
1,180
1,259
1,403
1,238
1,182
1,271
1,221
1,253
1,329
1,178
1,355
1,311
1,309
1,344
1,488
1,592
1,482
1,479
Expenses
397
464
578
498
449
525
670
609
549
503
585
594
631
640
746
700
696
672
774
731
762
835
944
864
857
993
986
979
1,152
1,152
1,109
1,086
1,138
1,167
1,271
1,251
1,186
1,184
EBITDA
97
111
340
396
142
173
167
196
100
87
184
161
207
172
351
208
154
228
361
321
417
424
459
374
325
279
235
274
178
26
246
225
171
178
216
340
295
295
Operating Profit %
19 %
19 %
37 %
44 %
24 %
25 %
20 %
24 %
15 %
15 %
23 %
21 %
25 %
21 %
32 %
23 %
18 %
25 %
32 %
31 %
27 %
34 %
33 %
30 %
26 %
22 %
18 %
21 %
13 %
2 %
18 %
17 %
13 %
12 %
14 %
21 %
20 %
20 %
Depreciation
11
13
13
22
24
19
20
22
22
22
26
26
28
25
26
27
27
33
33
34
36
36
37
38
42
43
54
56
122
67
67
66
74
66
67
69
69
69
Interest
0
0
1
1
1
1
1
0
1
1
0
1
1
1
5
5
4
5
7
7
7
6
2
2
2
2
5
4
6
9
12
15
14
14
15
15
10
13
Profit Before Tax
86
97
326
374
117
153
147
174
76
64
159
134
179
145
320
177
122
191
322
280
374
382
420
334
281
233
176
214
50
-49
167
144
84
98
134
257
216
213
Tax
11
19
74
78
27
33
33
36
17
14
36
29
34
31
69
39
14
36
53
49
60
63
72
57
50
41
33
37
8
0
21
25
-47
0
0
23
14
37
Net Profit
67
78
252
279
89
120
114
138
59
51
122
105
144
114
251
139
108
155
269
231
314
319
348
277
231
193
143
177
42
-49
146
119
131
98
134
233
202
176
EPS in ₹
3.56
4.15
13.38
41.80
4.70
6.35
6.04
7.31
3.14
2.69
6.48
5.57
7.65
6.05
13.32
7.35
5.71
8.23
14.25
12.26
16.67
16.90
18.02
14.11
11.76
9.80
7.28
8.99
2.11
-2.51
7.45
6.06
6.64
4.96
6.81
11.87
10.27
8.96
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,511
2,182
2,509
3,678
4,549
5,879
6,643
7,074
6,130
6,399
Fixed Assets
489
697
799
918
1,085
1,276
1,774
1,771
2,377
2,536
Current Assets
841
1,325
1,223
1,676
1,836
2,151
2,495
2,744
2,780
2,989
Capital Work in Progress
83
92
348
741
1,107
1,570
2,183
2,304
601
524
Investments
0
37
103
299
506
833
343
219
229
227
Other Assets
939
1,355
1,259
1,720
1,850
2,199
2,344
2,779
2,922
3,112
Total Liabilities
678
651
642
1,483
1,837
2,533
1,542
1,784
1,716
1,490
Current Liabilities
605
567
541
898
1,241
1,454
1,139
1,579
1,551
1,327
Non Current Liabilities
72
84
101
585
596
1,079
403
204
165
162
Total Equity
834
1,531
1,867
2,195
2,712
3,346
5,102
5,290
4,414
4,909
Reserve & Surplus
796
1,493
1,830
2,157
2,675
3,308
5,063
5,251
4,375
4,870
Share Capital
38
38
38
38
38
38
39
39
39
39
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
280
-280
9
135
-116
18
-40
8
-2
Investing Activities
-199
-292
-511
-794
-754
-822
-837
-369
-461
-329
Operating Activities
180
848
327
305
809
540
1,388
545
730
773
Financing Activities
18
-276
-96
498
80
166
-534
-217
-261
-445
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
69.48 %
69.48 %
69.48 %
69.48 %
69.61 %
69.61 %
69.61 %
69.61 %
69.61 %
69.61 %
69.61 %
69.61 %
69.61 %
69.61 %
FIIs
6.56 %
6.41 %
5.52 %
5.89 %
6.02 %
5.94 %
5.32 %
4.99 %
4.55 %
4.34 %
4.50 %
4.52 %
4.46 %
4.32 %
DIIs
10.97 %
11.25 %
11.42 %
11.60 %
11.74 %
12.15 %
12.54 %
12.76 %
13.31 %
13.65 %
14.22 %
14.50 %
15.39 %
15.47 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
12.99 %
12.86 %
13.58 %
13.03 %
12.63 %
12.30 %
12.53 %
12.65 %
12.53 %
12.40 %
11.67 %
11.37 %
10.54 %
10.60 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
Biocon
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
55.33
ATR(14)
Less Volatile
49.01
STOCH(9,6)
Neutral
61.95
STOCH RSI(14)
Neutral
55.09
MACD(12,26)
Bearish
-0.09
ADX(14)
Weak Trend
18.97
UO(9)
Bearish
52.06
ROC(12)
Downtrend And Accelerating
-1.35
WillR(14)
Neutral
-51.24
Bearish
5
Neutral
4
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.